MedTrace Logo

Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

NCT04780607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2021-03-03

No results posted yet for this study

Summary

rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the outcomes of middle or late-stage RHD patient, however, whether mitral valve repair surgery is superior to replacement or other evolving interventional device remains controversial, this study aims to investigate the results of repair surgery compared with replacement or other treatment strategy from international multicenters.

Conditions

  • Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

Interventions

DEVICE

mitral valve repair

different repair techniques to construct rheumatic mitral valve lesion

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    lead OTHER

Principal Investigators

  • xu meng, MD · Beijing Anzhen Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2024-01-01
Completion
2024-04-01
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780607 on ClinicalTrials.gov